JournalArta
Thursday, November 19, 2026 · JakartaS&P 7,323.63 ▼0.23%USD/IDR 18,263 ▲0.20%
JournalArta
Global Edition
beyond headlines
Advertisement

Aviva Share Price Falls 1.01% (November 18, 2026): Up 4% in a Month

Technical analysis of Aviva stock on November 18, 2026: price 742.60 GBp, trend uptrend, RSI 55.8, support 711.20, resistance 764.80.

By Alistair Sterling
November 19, 20265 min read
Aviva Share Price Falls 1.01% (November 18, 2026): Up 4% in a Month
Aviva Share Price Falls 1.01% (November 18, 2026)

Why Aviva is in focus today

    Selected automatically from 10 LSE (UK) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Aviva plc shares slipped 1.01% to 742.60 pence on the London Stock Exchange on Wednesday, a modest retreat that will matter little to international readers and a great deal to anyone reading the signals underneath it: the stock is still 3.98% higher over the past month, still sits above both of its key moving averages, and is doing so on volume that has quietly drained away. That divergence — price holding firm while participation thins — is the story of the session. The previous close was 750.20p, so the one-day move is a dent rather than a break. Over five sessions the shares are up 0.87%, and the 20-day average has risen 1.40% over the same stretch, a slope that confirms an established uptrend rather than a bounce. Aviva last traded at 734.59p on its 20-day average and 713.10p on its 50-day, so the price at 742.60p sits above both — the basic definition of a healthy structure. No new moving-average cross has formed, so there is no fresh signal to chase; this is an existing trend being tested, not a new one being born.
    Advertisement

    Trend & Price Action

    Position within the range matters more than the headline move. The shares are in the upper half of their 20-day band, 59% of the way between support at 711.20p and resistance at 764.80p. The three-month high of 768.60p and low of 668.60p frame a stock that has clawed back most of its autumn weakness but has not yet broken out. That ceiling near 764.80p coincides closely with the upper Bollinger band at 764.27p — two independent measures of the same obstacle, which makes it a level worth respecting rather than rounding past.
    Price action chart of Aviva
    3-month price action chart of Aviva: price, SMA20/50, Bollinger, support & resistance.
    The pullback to the 20-day average is the detail that matters. One of the two technical signals flagged in the data is precisely that: a pullback to the SMA20 within an uptrend, with price above the 50-day line at 713.10p. In plain terms, the stock has retraced toward the level where buyers previously stepped in without breaking the structure that made the rally possible.
    Advertisement

    Oscillators & Momentum

    Momentum is cooling rather than cracking. RSI(14) at 55.8 is squarely neutral — neither stretched nor exhausted, and comfortably clear of the 70 line that would signal overheating. The more telling reading is the bearish counter-signal: RSI rolling over from above 65. That is the fingerprint of a rally losing a little thrust, not of a trend reversing. The Stochastic adds a second caution. %K at 42.2 sits below %D at 63.0, a configuration that typically precedes short-term softness.
    Momentum chart of Aviva
    Momentum chart of Aviva: RSI(14), MACD, Stochastic.
    Yet MACD refuses to confirm the pessimism. The line at 11.005 remains above its signal at 10.109, with a positive histogram of 0.896. Momentum is still pointing up on this slower measure even as the faster oscillators fade. When short-term indicators disagree with the medium-term trend, the trend usually wins until proven otherwise — and here the trend is up.
    Advertisement

    Volatility & Volume

    Bollinger width of 8.1% is normal, neither squeezed nor expanded, and %B at 63% places the price in the upper-middle of the band. ATR of 13.77 points, or 1.9% of the price, describes moderate volatility — roughly £14 of average daily travel. For a general reader: bands this wide mean the stock has room to drift in either direction without anything dramatic being implied. Volume is where the caution bites. Last session moved 4.50 million shares against a 20-day average of 5.71 million — just 0.8× normal — and On-Balance Volume is falling. The accumulation measure declining while price edges higher is the weakest combination on the page, and it explains why the day's 1.01% fall deserves attention rather than dismissal.
    Advertisement

    Key Levels & Scenarios

    The levels are unusually clean. On the downside, 711.20p is the 20-day support, sitting just above the 50-day average at 713.10p — a cluster that should absorb ordinary pullbacks. Below that, 704.91p marks the lower Bollinger band. On the upside, 764.80p is the 20-day resistance, backed by the 768.60p three-month high; a close above both would open the path implied by the upper band structure. If the stock holds 711.20p, the uptrend narrative survives intact. If it fails there, the 50-day average comes into play immediately.

    Technical Verdict: BUY

    The verdict is BUY, carrying a computed score of +68 on a −100 to +100 scale, where +60 or above reads as a buy. Three reasons carry the weight: price trades above its 50-day average, the 20-day average itself sits above the 50-day, and the trend is rising with RSI at 55.8 in the healthy 50–70 zone. The fading oscillators and falling OBV are real risks, but they argue for patience on entry rather than a change of direction. - Entry zone: 732.30p – 742.60p - Exit targets: 793.82p and 845.05p - Stop loss: 708.45p - Reward-to-risk: 1.5 to 3.0 - Validity: through 16 December 2026 The verdict is invalidated if price breaks below 708.45p, which would undercut the support cluster and the lower band together. In plain English: the trend is intact and the setup favours holders, but the stock is pausing, not surging. The next scheduled event to watch is the 16 December validity date on these levels; until then, the market's own test comes at each close relative to 764.80p above and 711.20p below.
    Advertisement

    Market Data Snapshot

    Last Price742.60 GBp
    1-Day / 5-Day / 1-Month Change-1.01% / 0.87% / 3.98%
    SMA20 / SMA50734.59 / 713.10
    Bollinger (20,2σ)Upper 764.27 / Mid 734.59 / Lower 704.91; Width 8.1%
    RSI(14)55.8 (neutral)
    Stochastic %K / %D42.2 / 63.0
    MACD / Signal / Histogram11.005 / 10.109 / 0.896
    ATR(14)13.77 (1.9% of price)
    Volume vs 20-day Average4,500,649 vs 5,712,289 (0.8×)
    20-Day Support / Resistance711.20 / 764.80
    3-Month High / Low768.60 / 668.60
    JournalArta Research Score+68 (BUY)
    This is technical analysis for educational purposes and not an investment recommendation.

    Summary Data Aviva

    Last price742.60 GBp
    Change 1 day / 5 days / 1 month-1.01% / 0.87% / 3.98%
    Trend / MA-crossuptrend / none
    SMA20 / SMA50734.59 / 713.10
    RSI (14) / Stochastic %K55.8 / 42.2
    Bollinger %B / ATR63% / 13.77
    Support / Resistance 20 days711.20 / 764.80
    Data as of18 November 2026 23:47 WIB
    JournalArta research verdict (score)Buy (+68)
    Entry zone732.30 – 742.60
    Target 1 / 2793.82 / 845.05
    Stop loss708.45
    Reward/risk1.5 / 3.0
    Advertisement

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1Gold Silver Price November: Futures Rise Near Yearly Lows
    2. 2U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    3. 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
    4. 42027 NFL Mock Draft Puts Ohio State’s Jeremiah Smith at No. 1
    5. 5GTA 6 New Zealand Time Trick Is Not Guaranteed to Work
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Sport · More SportsFox Footy Phantom Draft Tips Cochrane as First PickNov 19
    2. Lifestyle · Food & HealthActinogen’s Daily Cortisol Pill Shows Mixed Alzheimer’s ResultsNov 19
    3. TechnologyArtex Speeds Up Hacking Attacks on Companies and BanksNov 19
    4. Business · Macro & PolicyFed Officials Expected More Rate Hikes After October Hold, Minutes SayNov 19
    5. Advertisement
    6. Markets · StocksBritish Land Share Price on Wednesday: Rises 1.62%, Up 2.2% in Five SessionsNov 19
    7. Markets · StocksAnthropic IPO Could Make Thousands of Staff MillionairesNov 19
    8. Markets · StocksInside India: Foreign Investors Pour $10 Billion Into StocksNov 19
    9. Business · CompaniesCanada Probes Old Navy, Gap Sale Prices and Online ClaimsNov 19